Frontiers in Cardiovascular Medicine

Original Research

Published on 21 Feb 2022

Regulation of Ion Channel Function in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Cancer Cell Secretion Through DNA Methylation

in Cardio-Oncology

Rujia Zhong
Feng Zhang
Zhen Yang
Yingrui Li
Qiang Xu
Huan Lan
Siegfried Lang
Lukas Cyganek
Elke Burgermeister
Ibrahim El-Battrawy

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.839104

3,185 views
4 citations

Original Research

Published on 17 Feb 2022

A Concomitant Cancer Diagnosis Is Associated With Poor Cardiovascular Outcomes Among Acute Myocardial Infarction Patients

in Cardio-Oncology

Xiang Peng
Zhuozhong Wang
Muhua Cao
Yuqi Zheng
Ya'nan Tian
Li Yu
Wenjun Ni
Shanjie Wang
Zhifeng Qin
Suhong Zhao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.758324

2,653 views
4 citations

Review

Published on 17 Feb 2022

Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension

in Cardio-Oncology

Zhengqing Ba
Ying Xiao
Ming He
Dong Liu
Hao Wang
Hanyang Liang
Jiansong Yuan

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.810262

8,919 views
10 citations

Brief Research Report

Published on 15 Feb 2022

BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors

in Cardio-Oncology

Biniyam G. Demissei
WenJian Lv
Nicholas S. Wilcox
Karyn Sheline
Amanda M. Smith
Kathleen M. Sturgeon
Chris McDermott-Roe
Kiran Musunuru
Bénédicte Lefebvre
Susan M. Domchek

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.833171

4,026 views
6 citations

Original Research

Published on 14 Feb 2022

Percutaneous Coronary Intervention in Patients With Gynecological Cancer: Machine Learning-Augmented Propensity Score Mortality and Cost Analysis for 383,760 Patients

in Cardio-Oncology

Nicole Thomason
Dominique J. Monlezun
Awad Javaid
Alexandru Filipescu
Efstratios Koutroumpakis
Fisayomi Shobayo
Peter Kim
Juan Lopez-Mattei
Mehmet Cilingiroglu
Gloria Iliescu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.793877

2,742 views
5 citations

Review

Published on 07 Feb 2022

New Insights in Early Detection of Anticancer Drug-Related Cardiotoxicity Using Perfusion and Metabolic Imaging

in Cardio-Oncology

Farah Cadour
Franck Thuny
Joevin Sourdon

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.813883

3,476 views
10 citations

Case Report

Published on 31 Jan 2022

Capecitabine and Warfarin Interaction: A Case Report With Review of Literature and Management Options

in Cardio-Oncology

Khalefa Althiab
Manal Aljohani
Sultan Alraddadi
Mohammed Algarni

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.707361

4,444 views
1 citation

Policy and Practice Reviews

Published on 28 Jan 2022

Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story

in Cardio-Oncology

Irma Bisceglia
Maria Laura Canale
Giuseppina Gallucci
Fabio Maria Turazza
Chiara Lestuzzi
Iris Parrini
Giulia Russo
Nicola Maurea
Vincenzo Quagliariello
Stefano Oliva

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.821193

6,322 views
4 citations

Original Research

Published on 28 Jan 2022

Soluble Urokinase Plasminogen Activator Receptor Is Associated With Subclinical Myocardial Impairment by Speckle Tracking Echocardiography in Lung Cancer Patients

in Cardio-Oncology

Ahmad S. Manshad
Fatima A. Ballout
Jeffrey A. Borgia
Jochen Reiser
Tochukwu M. Okwuosa

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.659524

2,030 views
3 citations

Mini Review

Published on 24 Jan 2022

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity

in Cardio-Oncology

Manrose Singh
Akito T. Nicol
Jaclyn DelPozzo
Jia Wei
Mandeep Singh
Tony Nguyen
Satoru Kobayashi
Qiangrong Liang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.839644

5,076 views
15 citations

Original Research

Published on 21 Jan 2022

D-Dimer Is a Predictive Factor of Cancer Therapeutics-Related Cardiac Dysfunction in Patients Treated With Cardiotoxic Chemotherapy

in Cardio-Oncology

Masayoshi Oikawa
Daiki Yaegashi
Tetsuro Yokokawa
Tomofumi Misaka
Takamasa Sato
Takashi Kaneshiro
Atsushi Kobayashi
Akiomi Yoshihisa
Kazuhiko Nakazato
Takafumi Ishida

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.807754

4,418 views
11 citations

Case Report

Published on 20 Jan 2022

Case Report: Two Myxomas of Different Echodensities on Transthoracic Echocardiography in One Patient

in Cardio-Oncology

Ling-Yun Kong
Xiao-Zheng Cui
Wei Xiang
Ling-Ling Chen
Li Li
Fang Liu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.770228

1,792 views
1 citation

Mini Review

Published on 17 Jan 2022

Novel Mechanisms of Anthracycline-Induced Cardiovascular Toxicity: A Focus on Thrombosis, Cardiac Atrophy, and Programmed Cell Death

in Cardio-Oncology

Silvio Antoniak
Sukanya Phungphong
Zhaokang Cheng
Brian C. Jensen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.817977

5,751 views
24 citations

Review

Published on 14 Jan 2022

Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity

in Cardio-Oncology

Dong-Woo Kang
Rebekah L. Wilson
Cami N. Christopher
Amber J. Normann
Oscar Barnes
Jordan D. Lesansee
Gyuhwan Choi
Christina M. Dieli-Conwright

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.805735

10,196 views
24 citations

Original Research

Published on 13 Jan 2022

Trpc6 Promotes Doxorubicin-Induced Cardiomyopathy in Male Mice With Pleiotropic Differences Between Males and Females

in Cardio-Oncology

Nadine Norton
Katelyn A. Bruno
Damian N. Di Florio
Emily R. Whelan
Anneliese R. Hill
Andrea Carolina Morales-Lara
Anna A. Mease
John M. Sousou
Jose A. Malavet
Lauren E. Dorn

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.757784

4,413 views
15 citations

Brief Research Report

Published on 13 Jan 2022

Myocardial PD-L1 Expression in Patients With Ischemic and Non-ischemic Heart Failure

in Cardio-Oncology

Ekaterina Kushnareva
Vladimir Kushnarev
Anna Artemyeva
Lubov Mitrofanova
Olga Moiseeva

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.759972

5,509 views
22 citations

Navigation group

Articles

Regulation of Ion Channel Function in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Cancer Cell Secretion Through DNA Methylation

A Concomitant Cancer Diagnosis Is Associated With Poor Cardiovascular Outcomes Among Acute Myocardial Infarction Patients

Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension

BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors

Percutaneous Coronary Intervention in Patients With Gynecological Cancer: Machine Learning-Augmented Propensity Score Mortality and Cost Analysis for 383,760 Patients

New Insights in Early Detection of Anticancer Drug-Related Cardiotoxicity Using Perfusion and Metabolic Imaging

Capecitabine and Warfarin Interaction: A Case Report With Review of Literature and Management Options

Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story

Soluble Urokinase Plasminogen Activator Receptor Is Associated With Subclinical Myocardial Impairment by Speckle Tracking Echocardiography in Lung Cancer Patients

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity

D-Dimer Is a Predictive Factor of Cancer Therapeutics-Related Cardiac Dysfunction in Patients Treated With Cardiotoxic Chemotherapy

Case Report: Two Myxomas of Different Echodensities on Transthoracic Echocardiography in One Patient

Novel Mechanisms of Anthracycline-Induced Cardiovascular Toxicity: A Focus on Thrombosis, Cardiac Atrophy, and Programmed Cell Death

Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity

Trpc6 Promotes Doxorubicin-Induced Cardiomyopathy in Male Mice With Pleiotropic Differences Between Males and Females

Myocardial PD-L1 Expression in Patients With Ischemic and Non-ischemic Heart Failure